News

Correction - Notice of Annual General Meeting
07 April 2009

Notice is hereby given that the Annual General Meeting ("AGM") of TyraTech, Inc. (AIM: TYR), will be held on 21 May 2009 at 12.00 noon (GMT) at the office of Buchanan Communications, 45 Moorfields, London EC2Y 9AE. You will be asked to consider and vote on the resolutions below. All of the resolutions will be proposed as ordinary resolutions.

Ordinary Business

To consider and, if thought fit, pass the following ordinary resolutions:

  1. To receive and adopt the accounts for the period ended 31 December 2008 and the reports of the Directors and auditors on them.
  2. To re-elect Dr. K. Noonan as a Director serving for a term of three years.
  3. To re-elect Mr. B. Riley as a Director serving for a term of three years.
  4. To receive and approve the Remuneration Committee Report.
  5. To re-appoint KPMG LLP as auditors of the Company until the conclusion of the next annual general meeting at which accounts are laid before the Company and to authorize the Directors to determine the remuneration of the auditors.

Stockholders of record of the Company at the close of business on 22 April 2009 are entitled to vote at the AGM and any postponements or adjournments of the meeting. A list of these stockholders is available at the offices of the Company at the following address in 1901 S. Harbor City Blvd, Suite 300, Melbourne, Florida, 32901, USA.

By order of the Board

Keith E. Bigsby
Company Secretary
1 April 2009

Notes

  1. Any member entitled to attend and vote at the AGM is entitled to appoint one or more proxies (who need not be a member of the Company) to attend and, on a poll, vote instead of the member. Completion and return of a form of proxy will not preclude a member from attending and voting at the meeting in person, should he/she subsequently decide to do so.
  2. In order to be valid, any form of proxy, power of attorney or other authority under which it is signed, or notarially certified office copy of such power or authority, must reach the Company's Registrars, Proxy Department, Computershare, Investor Services (Channel Islands) Limited, PO Box 83, Ordnance House, 31 Pier Road, St. Helier, Jersey JE4 8PW, not less than 48 hours before the time of the AGM or of any adjournment of the AGM.
  3. In the case of joint holders, where more than one of the joint holders purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear on the Company's register of stockholders in respect of the joint holding.
  4. Copies of the letters of appointment of each of the Directors, and the register of Directors' interest in shares of the Company will be available for inspection at the registered office of the Company during usual business hours on any weekday (Saturdays and Public holidays excluded) from the date of this notice until the date of the AGM and at the place of the AGM from at least 15 minutes prior to and until the conclusion of the AGM.
  5. Stockholders that have general queries about the AGM should contact one of the following individuals at the Company (no other methods of communication will be accepted):
    • Douglas Armstrong Ph.D., Chief Executive Officer +1 (321) 409 7723
    • Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

For further information please contact:

TyraTech Inc.
Alan Reade, Executive Chairman
www.tyratech.com

1 (321) 409 - 7720
Nomura Code Securities
Charles Walker/Clare Terlouw
www.nomuracode.com
+44 (0)20 7776 1200
Buchanan Communications
Mary-Jane Johnson/Lisa Baderoon/
Catherine Breen/Stasa Filiplic
www.buchanan.uk.com
+44 (0) 20 7466 5000

 

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company’s proprietary technology. TyraTech, which already has products on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech’s technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech’s platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

TyraTech is actively developing selected proprietary active ingredients which can then be used for various products across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium.

 

<< Back to News releases

Disclaimer for U.S. Site Visitors

This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.